The US Food and Drug Administration has cleared the Dexcom G7 15-Day Continuous Glucose Monitor (CGM) for people older than 18 with diabetes. It's the longest-lasting system on the market. The G7 ...

Dexcom has won a clearance from the FDA for its longest-lasting continuous glucose monitor, a 15-day version of its flagship G7 sensor. The new system, which boosts wear time up from the previous ...

Credit: Dexcom. The Dexcom G7 15 Day CGM system is a wearable sensor that continuously measures ... of 20,310 CGM-YSI matched pairs from 130 devices. Results showed that the overall MARD between ...

DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, announced today the FDA has cleared the Dexcom G7 15 Day Continuous ... 2021;23(3):195-202. If supply chains shift out of ...

In addition to a longer sensor time, the Dexcom G7 15 Day is the only available waterproof CGM, according to Dexcom. The new device includes medication logging in addition to activity and ...

Dexcom reaffirmed ... launch of the 15-day G7 system in the second half of 2025 represents a key milestone, poised to enhance market competitiveness. While freight costs and supply dynamics ...

The primary difference between the Dexcom G7 and the G7 15-Day lies in the sensor wear duration and accuracy. The Dexcom G7 15-Day offers standout features that elevate the user experience.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250410304660/en/ Dexcom G7 15 Day is now cleared in the ...

Easier glucose management with fewer monthly sensors and reduced monthly waste. Dexcom G7 15 Day * is now cleared in the US for people age 18 years and above with diabetes. Now the longest lasting ...

“The approval of Dexcom G7 15 Day marks another major innovation for Dexcom,” said Jake Leach, executive vice president and chief operating officer at Dexcom. “By listening to the needs of ...